US Patent Issued to AIM ImmunoTech on May 27 for "Therapeutic double stranded RNA and methods for producing the same" (Florida, New Jersey, Pennsylvania Inventors)

ALEXANDRIA, Va., June 17 -- United States Patent no. 12,312,376, issued on May 27, was assigned to AIM ImmunoTech Inc. (Ocala, Fla.).

"Therapeutic double stranded RNA and methods for producing the same" was invented by Thomas K. Equels (Ocala, Fla.), Vishwajeetsinh M. Atodaria (North Brunswick, N.J.), Victoria G. Scott (Langhorne, Pa.), David R. Strayer (Bryn Mawr, Pa.) and Peter W. Rodino (Fort Myers, Fla.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed is a method for the synthesis of a therapeutic double-stranded RNA (tdsRNA), comprising: a) synthesizing a first single-stranded RNA (first ssRNA) in a first synthesis reaction with PNPase as the only RNA polymerase; b) synthesizing a second single-...